(Q43977511)

English

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

scientific article published in May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

28 November 2017

1 reference

based on heuristic

inferred from title

arterial hypertension

1 reference

based on heuristic

inferred from title

Marius M Hoeper

11

1 reference

Europe PubMed Central

28 November 2017

Carmine Dario Vizza

object named as

Carmine Dario Vizza

4

0 references

object named as

Olivier Sitbon

7

0 references

object named as

Marc Humbert

2

0 references

Gérald Simonneau

15

object named as

Gerald Simonneau

1 reference

Europe PubMed Central

28 November 2017

8

object named as

Adam Torbicki

1 reference

Europe PubMed Central

28 November 2017

Jean-Luc Vachiéry

3

object named as

Jean-Luc Vachiéry

1 reference

Europe PubMed Central

28 November 2017

12

object named as

Ari Chaouat

1 reference

Europe PubMed Central

28 November 2017

Alessandra Manes

6

object named as

Alessandra Manes

1 reference

Europe PubMed Central

28 November 2017

Nazzareno Galié

1

object named as

Nazzareno Galiè

1 reference

Europe PubMed Central

28 November 2017

Marion Delcroix

9

object named as

Marion Delcroix

1 reference

Europe PubMed Central

28 November 2017

10

object named as

Robert Naeije

1 reference

Europe PubMed Central

28 November 2017

author name string

Meinhard Kneussl

5

1 reference

Europe PubMed Central

28 November 2017

Sophie Morand

13

1 reference

Europe PubMed Central

28 November 2017

Bruno Besse

14

1 reference

Europe PubMed Central

28 November 2017

Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group

16

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

28 November 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

28 November 2017

39

1 reference

Europe PubMed Central

28 November 2017

1496-1502

1 reference

Europe PubMed Central

28 November 2017

9

1 reference

Europe PubMed Central

28 November 2017

Primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary pulmonary hypertension: insights into pathogenesis from epidemiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Congenital heart disease in adults. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary vascular disorders in portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions between endothelial mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Do we need controlled clinical trials in pulmonary arterial hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Orally active prostacyclin analogue in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychophysical bases of perceived exertion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901786-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(02)01786-2

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43977511&oldid=2105224691"